Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37957249)

  • 1. Low EGFL7 expression is associated with high lymph node spread and invasion of lymphatic vessels in colorectal cancer.
    de Oliveira C; Martins SFF; Gonçalves PG; Limone GA; Longatto-Filho A; Reis RM; Bidinotto LT
    Sci Rep; 2023 Nov; 13(1):19783. PubMed ID: 37957249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of EGFL7 in human cancers: A review.
    de Oliveira C; Gonçalves PG; Bidinotto LT
    J Cell Physiol; 2023 Aug; 238(8):1756-1767. PubMed ID: 37490307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of EGFL7 regulating neovascularization in diabetic retinopathy through the PI3K/AKT/VEGFA pathway.
    Xian Y; Wang X; Yu Y; Chen X
    Life Sci; 2024 Mar; 340():122483. PubMed ID: 38307238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-126 inhibits tube formation of HUVECs by interacting with EGFL7 and down-regulating PI3K/AKT signaling pathway.
    Li Q; Cheng K; Wang AY; Xu QG; Fu ZF; He SY; Xu PX
    Biomed Pharmacother; 2019 Aug; 116():109007. PubMed ID: 31170663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.
    Luo BH; Xiong F; Wang JP; Li JH; Zhong M; Liu QL; Luo GQ; Yang XJ; Xiao N; Xie B; Xiao H; Liu RJ; Dong CS; Wang KS; Wen JF
    PLoS One; 2014; 9(6):e99922. PubMed ID: 24945379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VE-statin/Egfl7 expression in malignant glioma and its relevant molecular network.
    Huang C; Yuan X; Wan Y; Liu F; Chen X; Zhan X; Li X
    Int J Clin Exp Pathol; 2014; 7(3):1022-31. PubMed ID: 24696719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell RNA sequencing reveals differential expression of EGFL7 and VEGF in giant-cell tumor of bone and osteosarcoma.
    Feleke M; Feng W; Song D; Li H; Rothzerg E; Wei Q; Kõks S; Wood D; Liu Y; Xu J
    Exp Biol Med (Maywood); 2022 Jul; 247(14):1214-1227. PubMed ID: 35695550
    [No Abstract]   [Full Text] [Related]  

  • 8. EGFL7 drives the evolution of resistance to EGFR inhibitors in lung cancer by activating NOTCH signaling.
    Wang Y; Chen P; Zhao M; Cao H; Zhao Y; Ji M; Hou P; Chen M
    Cell Death Dis; 2022 Oct; 13(10):910. PubMed ID: 36309484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Egfl7 correlates with low-grade invasive lesions in human breast cancer.
    Philippin-Lauridant G; Baranzelli MC; Samson C; Fournier C; Pinte S; Mattot V; Bonneterre J; Soncin F
    Int J Oncol; 2013 Apr; 42(4):1367-75. PubMed ID: 23404186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting SMYD2 inhibits angiogenesis and increases the efficiency of apatinib by suppressing EGFL7 in colorectal cancer.
    Zhang Y; Zhou L; Xu Y; Zhou J; Jiang T; Wang J; Li C; Sun X; Song H; Song J
    Angiogenesis; 2023 Feb; 26(1):1-18. PubMed ID: 35503397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor-like domain 7 promotes cell invasion and angiogenesis in pancreatic carcinoma.
    Shen X; Han Y; Xue X; Li W; Guo X; Li P; Wang Y; Li D; Zhou J; Zhi Q
    Biomed Pharmacother; 2016 Feb; 77():167-75. PubMed ID: 26796281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of epidermal growth factor-like domain 7 is correlated with poor differentiation and poor prognosis in patients with epithelial ovarian cancer.
    Oh J; Park SH; Lee TS; Oh HK; Choi JH; Choi YS
    J Gynecol Oncol; 2014 Oct; 25(4):334-41. PubMed ID: 25142627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Activation of
    Sznurkowski JJ; Żawrocki A; Krawczyńska N; Bieńkowski M; Wasąg B; Biernat W
    Medicina (Kaunas); 2022 Apr; 58(5):. PubMed ID: 35630004
    [No Abstract]   [Full Text] [Related]  

  • 14. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis.
    Hong G; Kuek V; Shi J; Zhou L; Han X; He W; Tickner J; Qiu H; Wei Q; Xu J
    J Cell Physiol; 2018 Nov; 233(11):8526-8537. PubMed ID: 29923200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High
    Cheng Z; Dai Y; Pang Y; Jiao Y; Liu Y; Cui L; Qian T; Quan L; Cui W; Pan Y; Ye X; Shi J; Fu L
    Cancer Biol Ther; 2019; 20(10):1314-1318. PubMed ID: 31306053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFL7: a unique angiogenic signaling factor in vascular development and disease.
    Nichol D; Stuhlmann H
    Blood; 2012 Feb; 119(6):1345-52. PubMed ID: 22160377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGF repeats of epidermal growth factor‑like domain 7 promote endothelial cell activation and tumor escape from the immune system.
    Pinte S; Delfortrie S; Havet C; Villain G; Mattot V; Soncin F
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34738625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFL7 expression profile in IDH-wildtype glioblastomas is associated with poor patient outcome.
    da Costa BHB; Becker AP; Neder L; Gonçalves PG; de Oliveira C; Polverini AD; Clara CA; Teixeira GR; Reis RM; Bidinotto LT
    J Pathol Transl Med; 2022 Jul; 56(4):205-211. PubMed ID: 35698739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFL7 regulates sprouting angiogenesis and endothelial integrity in a human blood vessel model.
    Usuba R; Pauty J; Soncin F; Matsunaga YT
    Biomaterials; 2019 Mar; 197():305-316. PubMed ID: 30684886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.